Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, has signed a Drug Product manufacturing contract with CoreRx, a Contract Development Manufacturing Organization (CDMO), for formulating Brilacidin into granular form in unit dose sachets. Such drug product packaging in the form of sachets provides patients with a convenient, portable, quick-mixing “instant” Brilacidin oral rinse therapy. Sachets are…